The Medicine Maker: ‘The Pandemic Diaries’

Check out our recent contribution to The Medicine Makers’ ‘Pandemic Diaries’ segment. For this ‘In My View’ piece, our CEO, Andy Chaloner discusses the shift in business priorities and resulting opportunities during the COVID-19 pandemic with Stephane Argivier, CEO of MIP Diagnostics. The result has been a collaboration between Stream Bio and MIP Diagnostics, and a project to develop a highly sensitive diagnostic reagent for SARS-CoV-2.

Click here to read the article.